[HTML][HTML] Clinical and virological data of the first cases of COVID-19 in Europe: a case series

…, D Nguyen, M Parisey, PH Wicky, S Behillil… - The Lancet Infectious …, 2020 - thelancet.com
Background On Dec 31, 2019, China reported a cluster of cases of pneumonia in people at
Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe …

[HTML][HTML] Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies

…, E Bishop, M Albert, F Donati, M Prot, S Behillil… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …

[HTML][HTML] First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

…, B Coignard, S Bernard-Stoecklin, S Behillil… - …, 2020 - eurosurveillance.org
In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020.
We detail the first European cases. As at 21 February, nine European countries reported 47 …

Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

…, N Ettahar, X Lemaire, F Vuotto, A Goffard, S Behillil… - The Lancet, 2013 - thelancet.com
Background Human infection with a novel coronavirus named Middle East Respiratory
Syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia and the Middle East in …

[HTML][HTML] First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020

…, M Nguyen, C Bassi, E Yamani, S Behillil… - …, 2020 - eurosurveillance.org
Sylvie Behillil and Vincent Enouf contributed to the laboratory confirmation of 2019-nCoV
infection in the three imported cases, as well as the testing of samples of possible cases. …

[HTML][HTML] Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

P Maisonnasse, J Guedj, V Contreras, S Behillil… - Nature, 2020 - nature.com
Coronavirus disease 2019 (COVID-19) has rapidly become a global pandemic and no antiviral
drug or vaccine is yet available for the treatment of this disease 1 , 2 – 3 . Several clinical …

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

…, P Morel, S Rolland, FA Rey, S Behillil… - Science translational …, 2020 - science.org
It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …

Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission

…, M Beretta, F Donati, M Albert, F Gambaro, S Behillil… - BioRxiv, 2021 - biorxiv.org
Receptor recognition is a major determinant of viral host range, as well as infectivity and
pathogenesis. Emergences have been associated with serendipitous events of adaptation upon …

[HTML][HTML] Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus

S Temmam, A Barbarino, D Maso, S Behillil, V Enouf… - One health, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan,
China, in 2019, is responsible for the COVID-19 pandemic. It is now accepted that the wild …

Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa

…, F Ribadeau-Dumas, J Thèze, AS Le Guern, S Behillil… - Dermatology, 2011 - karger.com
Background: Antibiotics have been shown to improve hidradenitis suppurativa (HS) patients
but complete remission is rare using these treatments. Objective: To assess the efficacy and …